HFM
TEVA icon

Harvest Fund Management’s Teva Pharmaceuticals TEVA Stock Holding History

Harvest Fund Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-615
Closed -$19K – 553
2026
Q1 		$19K Hold
615
– – ﹤0.01% 401
2025
Q4 		$19K Buy
+615
New +$15.2K ﹤0.01% 477
2024
Q4 		– Sell
-605
Closed -$11K – 832
2024
Q3 		$11K Buy
+605
New +$10.6K ﹤0.01% 516

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Harvest Fund Management's TEVA Position: Q2 2026 in Review

Harvest Fund Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 615 shares — an estimated $19K sold.

Harvest Fund Management first reported a position in TEVA in Q3 2024 and held it in 3 quarters. The position peaked at $19K in Q1 2026. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Harvest Fund Management reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Harvest Fund Management sold 615 Teva Pharmaceuticals shares in Q2 2026, an estimated $19K.
  • Harvest Fund Management first reported a position in Teva Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • Harvest Fund Management's Teva Pharmaceuticals position peaked at $19K in Q1 2026.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.